Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Greenwich Lifesciences Inc (NQ: GLSI )

12.35 -0.25 (-1.98%)
Streaming Delayed Price Updated: 3:04 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Greenwich Lifesciences Inc

< Previous 1 2 3 Next >
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
GLSI Stock Earnings: Greenwich LifeSciences Misses EPS for Q4 2023
GLSI stock results show that Greenwich LifeSciences missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Insiders Buying Greenwich LifeSciences And 2 Other Stocks
Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades. 
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for Greenwich LifeSciences: Here's What You Need To Know
Via Benzinga
Why Greenwich Lifesciences (GLSI) Stock Is Skyrocketing
Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III clinical trial, Flamingo-01. 
Via Benzinga
Greenwich LifeSciences Inc. (NASDAQ: GLSI) Near the Top of Equities by Percentage Gain on 2/14
Via Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
$4.7 Million Bet On Tilly's? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed higher on Tuesday, there were a few notable insider trades. 
Via Benzinga
Greenwich LifeSciences Provides Year End Update
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023
From Greenwich LifeSciences, Inc.
Via Business Wire
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday
Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share. 
Via Benzinga
Bitcoin Holder MicroStrategy And 4 More Short Squeeze Stocks That Could Soar This Week
Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move. 
Via Benzinga
Virgin Orbit And 4 More Short Squeeze Stocks That Could Soar This Week — Including A Stock Moving Up 968 Positions
Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the... 
Via Benzinga
GLSI, AVTE: The Top 5 Short Squeeze Stocks to Watch This Week
Short-squeeze stocks continue to be a big deal for speculative traders and we're helping them out with a list to keep in mind this week! 
Via InvestorPlace
TOP Ships, Weber And 3 More Short Squeeze Stocks That Could Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the... 
Via Benzinga
TOPS, SURG: The Top 5 Short Squeeze Stocks This Week
Short squeeze stocks are still popular with speculative traders and that has us going over the top ones to keep an eye on this week! 
Via InvestorPlace
GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week
Investors are still interested in short squeeze stocks lately and we've got them covered with the ones to watch this week! 
Via InvestorPlace
Grenwich LilfeSciences, Blue Apron And 3 More Short Squeeze Candidates That May Soar
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week... 
Via Benzinga
NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week
Traders continue to show interest in short squeeze stocks this week as they seek out likely targets that will run higher. 
Via InvestorPlace
5 Short Squeeze Stocks That Could Soar: NeruoBo Pharmaceuticals, FaZe Holdings And More
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week... 
Via Benzinga
ATHX, PETS: The Top 5 Short Squeeze Stocks to Watch This Week
We're starting off another week with a deep dive into the short squeeze stocks traders are going to want to keep an eye on! 
Via InvestorPlace
10 Short Squeeze Candidates That May Soar: Athersys, TDH Holdings, FaZe Holdings, Weber And More
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week... 
Via Benzinga
MICS, REV: The Top 5 Short Squeeze Stocks to Watch This Week
Investors looking for the most likely short squeeze stocks to watch this week are in the right place with a list of the top five to watch! 
Via InvestorPlace
Revlon Climbs, Singing Machine Moves Up And Weber Makes Big Move: 5 Short Squeeze Stocks That May Soar This Week
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. 
Via Benzinga
Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial
From Greenwich LifeSciences, Inc.
Via Business Wire
7 Short-Term Stocks to Buy for a Quick Profit
Although the market has been volatile this year, the wildness also creates opportunities for short-term stocks to buy for a quick profit. 
Via InvestorPlace
5 Short Squeeze Stocks That May Soar Plus 5 To Watch: ToughBuilt, Redbox, Revlon And More
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. 
Via Benzinga
Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Provides Financing Strategy & Corporate Update
From Greenwich LifeSciences, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.